Published in Cancer Weekly, December 30th, 2003
Investigators say the results of the study of 11,085 women should facilitate earlier treatment, while allowing others to avoid unnecessary, invasive follow-up procedures.
The study was published in the December 6, 2003, issue of The Lancet
The research used Digene Corp.'s (DIGE) DNAwithPap Test, which is the only Food and Drug Administration (FDA)-approved test that detects the presence of the human papillomavirus - the primary cause...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.